David M. Cook

4.1k total citations
81 papers, 2.9k citations indexed

About

David M. Cook is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, David M. Cook has authored 81 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Endocrinology, Diabetes and Metabolism, 17 papers in Surgery and 11 papers in Genetics. Recurrent topics in David M. Cook's work include Growth Hormone and Insulin-like Growth Factors (47 papers), Pituitary Gland Disorders and Treatments (42 papers) and Adrenal and Paraganglionic Tumors (14 papers). David M. Cook is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (47 papers), Pituitary Gland Disorders and Treatments (42 papers) and Adrenal and Paraganglionic Tumors (14 papers). David M. Cook collaborates with scholars based in United States, United Kingdom and Sweden. David M. Cook's co-authors include Beverly M. K. Biller, Kevin C.J. Yuen, Laurence Katznelson, David L. Kleinberg, Vivien Bonert, Shereen Ezzat, Amir H. Hamrahian, John L. D. Atkinson, Mary H. Samuels and Mary Lee Vance and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

David M. Cook

81 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David M. Cook United States 30 2.3k 729 355 318 313 81 2.9k
Robert J. Ferry United States 25 1.2k 0.5× 725 1.0× 646 1.8× 465 1.5× 307 1.0× 70 2.5k
A S Paul van Trotsenburg Netherlands 30 1.9k 0.8× 665 0.9× 533 1.5× 776 2.4× 700 2.2× 128 3.4k
William Drake United Kingdom 25 1.5k 0.6× 527 0.7× 288 0.8× 460 1.4× 211 0.7× 83 2.2k
Jean‐Christophe Thalabard France 29 642 0.3× 584 0.8× 429 1.2× 617 1.9× 333 1.1× 92 3.2k
Thomas Schreiner Norway 31 1.1k 0.5× 314 0.4× 441 1.2× 446 1.4× 209 0.7× 84 2.8k
Teresa Quattrin United States 24 1.1k 0.5× 591 0.8× 744 2.1× 520 1.6× 207 0.7× 74 2.3k
Klemens Raile Germany 30 1.9k 0.8× 1.2k 1.7× 1.5k 4.2× 664 2.1× 302 1.0× 113 3.3k
Toshiaki Tanaka Japan 25 2.4k 1.1× 347 0.5× 773 2.2× 997 3.1× 791 2.5× 175 3.5k
Dana Erickson United States 28 2.3k 1.0× 1.3k 1.8× 97 0.3× 154 0.5× 42 0.1× 116 3.2k
Max E. Stachura United States 26 1.0k 0.5× 386 0.5× 150 0.4× 152 0.5× 167 0.5× 71 2.1k

Countries citing papers authored by David M. Cook

Since Specialization
Citations

This map shows the geographic impact of David M. Cook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Cook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Cook more than expected).

Fields of papers citing papers by David M. Cook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Cook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Cook. The network helps show where David M. Cook may publish in the future.

Co-authorship network of co-authors of David M. Cook

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Cook. A scholar is included among the top collaborators of David M. Cook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Cook. David M. Cook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anagnostopoulos, Christos, et al.. (2016). Stakeholder Communication in 140 Characters or Less: A Study of Community Sport Foundations. VOLUNTAS International Journal of Voluntary and Nonprofit Organizations. 28(5). 2224–2250. 38 indexed citations
2.
Yuen, Kevin C.J., Maria Kołtowska‐Häggström, David M. Cook, et al.. (2013). Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic–pituitary dysfunction. European Journal of Endocrinology. 169(4). 511–519. 35 indexed citations
3.
Biller, Beverly M. K., Vera Popović, Mihail Coculescu, et al.. (2012). 12-Month effects of once-weekly sustained-release growth hormone treatment in adults with GH deficiency. Pituitary. 16(3). 311–318. 21 indexed citations
4.
Yuen, Kevin C.J., Beverly M. K. Biller, Laurence Katznelson, et al.. (2012). Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults. Pituitary. 16(2). 220–230. 36 indexed citations
5.
Biller, Beverly M. K., Vera Popović, Mihail Coculescu, et al.. (2011). Effects of Once-Weekly Sustained-Release Growth Hormone: A Double-Blind, Placebo-Controlled Study in Adult Growth Hormone Deficiency. The Journal of Clinical Endocrinology & Metabolism. 96(6). 1718–1726. 36 indexed citations
6.
Katznelson, Laurence, John L. D. Atkinson, David M. Cook, et al.. (2011). American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly—2011 Update: Executive Summary. Endocrine Practice. 17(4). 636–646. 88 indexed citations
7.
Fleseriu, Maria, Johnny B. Delashaw, & David M. Cook. (2010). Acromegaly: a review of current medical therapy and new drugs on the horizon. Neurosurgical FOCUS. 29(4). E15–E15. 16 indexed citations
10.
Yuen, Kevin C.J., et al.. (2007). Is further evaluation for growth hormone (GH) deficiency necessary in fibromyalgia patients with low serum insulin-like growth factor (IGF)-I levels?. Growth Hormone & IGF Research. 17(1). 82–88. 21 indexed citations
11.
Cook, David M.. (2005). Long-Term Management of Prolactinomas—Use of Long-Acting Dopamine Agonists. Reviews in Endocrine and Metabolic Disorders. 6(1). 15–21. 6 indexed citations
13.
Yuen, Kevin C.J., Ken K. Ong, Pierre Chatelain, et al.. (2002). The Effects of Short-Term Administration of Two Low DosesVersusthe Standard GH Replacement Dose on Insulin Sensitivity and Fasting Glucose Levels in Young Healthy Adults. The Journal of Clinical Endocrinology & Metabolism. 87(5). 1989–1995. 30 indexed citations
14.
Yuen, Kevin C.J., David M. Cook, Ken K. Ong, et al.. (2002). The metabolic effects of short‐term administration of physiological versus high doses of GH therapy in GH deficient adults. Clinical Endocrinology. 57(3). 333–341. 25 indexed citations
15.
Cook, David M., Beverly M. K. Biller, M. L. Vance, et al.. (2002). The Pharmacokinetic and Pharmacodynamic Characteristics of a Long-Acting Growth Hormone (GH) Preparation (Nutropin Depot) in GH-Deficient Adults. The Journal of Clinical Endocrinology & Metabolism. 87(10). 4508–4514. 75 indexed citations
16.
Hawn, Mary T., David M. Cook, Clifford W. Deveney, & Brett C. Sheppard. (2002). Quality of life after laparoscopic bilateral adrenalectomy for Cushing's disease. Surgery. 132(6). 1064–1069. 107 indexed citations
17.
Cook, David M.. (1999). Adult growth hormone deficiencysyndrome: A personal approach to diagnosis, treatment and monitoring. Growth Hormone & IGF Research. 9. 129–133. 2 indexed citations
18.
Newman, Connie B., Шломо Мелмед, Ajax E. George, et al.. (1998). Octreotide as Primary Therapy for Acromegaly1. The Journal of Clinical Endocrinology & Metabolism. 83(9). 3034–3040. 14 indexed citations
19.
Cook, David M.. (1997). ADRENAL MASS. Endocrinology and Metabolism Clinics of North America. 26(4). 829–852. 22 indexed citations
20.
Cook, David M., et al.. (1986). GONADOTROPHIN‐SECRETING PITUITARY ADENOMAS MASQUERADING AS PRIMARY OVARIAN FAILURE. Clinical Endocrinology. 25(6). 729–738. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026